Accelerating Medicines Partnership® SCHIZOPHRENIA
News and Updates
Keep up with the latest news about the Accelerating Medicines Partnership (AMP®) SCZ program.

Recruitment Updates

December 1, 2022: 151 individuals have been consented across 18 sites into the AMP SCZ study. Of these participants, 80 completed screening and are in baseline or months 1 – 4.

Last Reviewed on December 1, 2022